Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for OA Pain in China
NCT01931475Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of duloxetine in osteoarthritis (OA), sponsored by Eli Lilly and Company. Started Sep 2013; status: completed.
02
Drugs
duloxetine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01931475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01931475.